Evidence map›Paper›PMID 41556338›Full record

ArticleNucleic acids research2026

Mbd4 and MutSα protect cells from spontaneous deamination of 5-methylcytosine.

Rebecca A Bilardi, Christoffer Flensburg, Zhen Xu, Emily B Derrick, Andrew Kueh, Ian J Majewski

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rebecca A BilardiBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.
Christoffer FlensburgBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.
Zhen XuBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.
Emily B DerrickCancer Immunology Program, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC 3000, Australia.
Andrew KuehBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.
Ian J MajewskiBlood Cells and Blood Cancer Division, The Walter and Eliza Hall Institute, 1G Royal Pde, Parkville, VIC 3052, Australia.ORCID 0000-0002-6087-635X

Funding

IRIISSLeukaemia FoundationNational Collaborative Research Infrastructure StrategyNCRISNHMRCNHMRC APP1145912SERPWEHI
6 · The paper itself

Abstract

5-Methylcytosine (5mC) is a common source of somatic mutations. Deamination of 5mC to thymine generates a G/T mismatch, which occurs spontaneously and must be repaired prior to DNA replication to avoid mutation. We generated genetically engineered mice and cell lines to define DNA repair pathways that protect against 5mC deamination. We observed a low background mutation rate in mouse bone marrow or colon, typically 0.2-0.5 CG > TG mutations/genome/day. This increased 3-7 fold in cells lacking the glycosylase methyl-binding domain 4 (Mbd4), one of the few glycosylases capable of excising thymine from G/T mismatches. We found no role for thymine DNA glycosylase (Tdg) in the repair of 5mC deamination in these tissues. Instead, our results flag potential cooperation between Mbd4 and the mismatch repair (MMR) complex MutSα (Msh6:Msh2), evident through elevated rates of CG > TG mutations in Msh6-deficient cells: 2.6-4.8 CG > TG mutations/genome/day in primary cells and 13.9 CG > TG mutations/genome/day in cell lines. Loss of Mbd4 results in a specific increase in DNA damage from 5mC deamination, whereas the broader functionality of MutSα explains why mutational signatures linked to Msh6 deficiency are more variable and reflect the replicative history of the cell. Our findings support the emerging view that MutSα has broader DNA repair activity outside of replication.

Indexed as

5-MethylcytosineEndodeoxyribonucleasesAnimalsCell LineDeaminationDNA-Binding ProteinsDNA DamageDNA Mismatch RepairDNA RepairHumansMiceMutationMutS Homolog 2 ProteinThymine DNA Glycosylase5-MethylcytosineDNA-Binding ProteinsEndodeoxyribonucleasesMbd4 protein, mouseMsh2 protein, mouseMsh6 protein, mouseMutS Homolog 2 ProteinThymine DNA Glycosylase

Identifiers

PMID41556338
PMCPMC12817082

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.